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INTRODUCTION 
Gastric cancer mortality has been fallen 
throughout Europe during the past decades in 
terms of both incidence and mortality rates.1, 2,3 
It is mainly as a result of remarkable improve-
ment of life conditions in European societies.4-7 
Efforts to reduce global cancer disparities begin 
with an understanding of geographic patterns of 
cancer incidence, mortality and prevalence rates, 
by studies such as GLOBOCAN,8,9 EURO-
CARE,10 and Five Continents databases.11 Sur-
vival increased and mortality decreased through 
the combination of earlier detection, better ac-
cess to care and improved treatment.12 There has 
also been a concomitant change in lifestyle and 
environmental exposures over successive gen-
erations,13 including changes in exposures to risk 
factors in early decades of life.14 
Several studies conducted to determine the 
projections of future trends in gastric cancer 
mortality in European countries.7,12,14-17 Mortal-
ity rates were generally expected to decline fur-
ther. Based on the cancer mortality trends in the 
European Union until 2000, one study predicted 
a further fall by 11% in age-standardized cancer 
mortality from 2000 to 2015.15 A Dutch study 
also projected a substantial decline in gastric 
cancer mortality until 2015, based on trends 
until 2000.16 Similarly, an Irish study predicted 
mortality from gastric cancer to fall further in 
the near future, although with a slower rate than 
in the recent past.17  
Determinations of future mortality trends 
should be based on a careful analysis of trends in 
the past.18, 19 Therefore, in a study, the analysis  
started with a description of trends in gastric 
cancer mortality over a long period, from 1980 
up to 2005, in order to check whether mortality 
decline continued undiminished until recent 
years.20 In addition, it has been assessed whether 
the rate of decline was similar in all seven coun-
tries and both sexes, despite differences in over-
all rates of gastric mortality.  
The noticeable decline in gastric cancer mor-
tality was found to continue at an undiminished 
rate until 2005 in each of the seven European 
countries. If this decline were to continue in the 
future, gastric cancer mortality rates would de-
crease with about 66 percent between 2005 and 
2030. A two-thirds decline would also observe in 
terms of the effect of gastric cancer on people’s 
life expectancy at birth. The absolute number of 
gastric cancer deaths would diminish by about 
50 percent despite the ageing of national popula-
tions. Thus, by extrapolating the strong, stable 
and consistent mortality rate declines in recent 
decades, gastric cancer was projected to become 
increasingly less important as a cause of death in 
Europe in the next decades. 
Empirical support for the expectation that the 
decline in mortality from gastric cancer will con-
tinue in the future comes from the trends that 
were studied in the past 25 years. First, a strong 
consistency exists in the recent trends in gastric 
cancer mortality among both sexes and among 
each of the seven European countries. Second, 
these declines have persisted up to recent years 
in each of these populations, including those 
with the lowest initial mortality rates. Further-
more, a steady decline in gastric cancer mortal-
ity rate was  observed in the middle-aged and 
the young population as well, suggesting that 
they are likely to continue in the near future.3, 4, 
15 The latter observation is consistent with analy-
sis of cohort-wise patterns of decline in gastric 
cancer mortality in European countries,1 13, 21 
which may reflect the effects of life style im-
provement  in childhood.1  
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It should be emphasized that, even though fu-
ture declines may seem likely, in this  study, we 
primarily aimed to explore possible future trends 
by extrapolating past trends. This extrapolation 
would provide  a baseline scenario against 
which new studies may formulate more specific 
scenarios of future trends. For example, policy-
based scenarios may focus on the potential ef-
fects of specific preventive policies or advance-
ment in the treatment of gastric cancer. As the 
gastric cancer may become ever less important 
in terms of mortality, scenario studies will need 
to also include measures of incidence, prognosis 
and prevalence of gastric cancer. 
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